CNS
-
ข่าว
JAS Soars 13% in Anticipation of Outperforming Results in 2021
JAS soared 13% in anticipation of potential recovery in 2021 and the possibility of receiving a claim worth 4.5 billion baht.
-
ข่าว
Stocks in Focus on June 14, 2021: CKP and SCGP
Stocks in Focus on June 14, 2021: CKP (Maybank Kim Eng TP at ฿6.50/share) and SCGP (Capital Nomura Securities TP at ฿60.00/share).
-
Kaohoon International
KBANK Falls 2.5% after the Delist from MSCI, CNS Expects no Impact on Fundamentals
CNS saw no impact on KBANK’s fundamental after the delist from MSCI Global Standard, expecting an opportunity for “Accumulative Buy”
-
Kaohoon International
Stocks in Focus on May 27, 2021: PTT and TOA
Stocks in Focus on May 27, 2021: PTT (Maybank Kim Eng TP at ฿53.00/share) and TOA (Capital Nomura Securities TP at ฿41.00/share).
-
Kaohoon International
Stocks in Focus on May 21, 2021: CHG and KCE
Stocks in Focus on May 21, 2021: CHG (Kingsford TP at ฿3.66/share) and KCE (Capital Nomura Securities TP at ฿70.00/share).
-
Kaohoon International
Stocks in Focus on May 19, 2021: SCGP and SABINA
Stocks in Focus on May 19, 2021: SCGP (Capital Nomura Securities TP at ฿60.00/share) and SABINA (Maybank Kim Eng TP at ฿24.00/share).
-
Breaking News
Consensus Rates “BUY” on HMPRO over Strong Growth Forecast in 2Q amid Covid-19
Analysts recommended a "BUY" rating on HMPRO following the company's better-than-expected results in the first quarter of this year, which was attributed to tighter cost management…
-
Kaohoon International
CNS Picks STGT, KEX, IRPC and STA as Candidates for SET50 Additions in 2H
CNS expected STGT, STA, KEX and IRPC to be the main candidates for the SET50 additions in the second half of 2021.
-
Kaohoon International
TU Jumps 6.5% to Bt17.90, CNS Recomm. “BUY” at Bt20 on Strong Recovery in U.S. and Europe
The share price of TU jumped 6.5% after reporting a satisfying 1Q21 earnings. CNS recommended "BUY" at a target price of Bt20.00 per share.
-
Breaking News
AstraZeneca Covid Vaccine Get Closer to Deliver to Thailand, Analysts Recomm. Global Play
AstraZeneca announced the samples from test batches of the Covid-19 vaccine made by Siam Bioscience had passed quality testing and the delivery is getting closer.
-
Kaohoon International
GLOBAL Increases 3% after a Record High in 1Q Earnings, CNS Expects to Outperform Peers
GLOBAL jumped as much as 7.6% after a recod high in 1Q earnings. CNS expected GLOBAL to outperform its peers, giving a TP at Bt28 per share.
-
Kaohoon International
CNS Expects Weak Baht to Benefit CPF with Positive Momentum after Breaking Bt30.75 Level
CNS Expects Weak Baht to Benefit CPF with Positive Momentum after Breaking the Bt30.75 Resistance Level.